Literature DB >> 7060254

Estimation of acute myocardial infarct size in man by serum CK-MB measurements.

P Grande, B F Hansen, C Christiansen, J Naestoft.   

Abstract

This study was performed to determine the relationship between myocardial infarct size estimated by serum CK-MB methods and the extent of irreversible injury in acute myocardial infarction. In 321 consecutive patients, infarct size was estimated by different mathematical models, and in 22 patients who died in hospital, the extent of myocardial necrosis was determined by autopsy. We also investigated the depletion of CK-MB in infarcted tissue, the recovery of CK-MB in the plasma volume, and the estimation of CK-MB from plasma. Myocardial CK-MB depletion was relatively greater in the larger infarcts, whereas the recovery of enzyme in plasma was independent of the infarct size. Correction of serum CK-MB for changes in plasma volume improved the estimate significantly (p less than 0.05). The correlation between the measured infarct size (g) and the estimated infarct size (units per liter and gram-equivalents) was highly significant (r = 0.85--0.89, SEE = 23--27%, p less than 0.001). Thus, a semiquantitative expression of the extent of myocardial necrosis can be determined in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060254     DOI: 10.1161/01.cir.65.4.756

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction?

Authors:  J K Kjekshus
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

2.  Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI.

Authors:  Gert Klug; Agnes Mayr; Johannes Mair; Michael Schocke; Michael Nocker; Thomas Trieb; Werner Jaschke; Otmar Pachinger; Bernhard Metzler
Journal:  Clin Res Cardiol       Date:  2011-01-04       Impact factor: 5.460

3.  Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction.

Authors:  K Pietilä; A Harmoinen; L Pöyhönen; M Koskinen; J Heikkila; R Ruosteenoja
Journal:  Br Heart J       Date:  1987-09

4.  Limitation of myocardial infarct size. Present status.

Authors:  S Yusuf; P Sleight
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

5.  Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction.

Authors:  C de Zwaan; G M Willems; F Vermeer; J Res; F W Verheugt; A van der Laarse; M L Simoons; J Lubsen; W T Hermens
Journal:  Br Heart J       Date:  1988-02

6.  Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.

Authors:  James Chek; Jaroslav Dusek; Josef Stasek; Jan Vojacek; Josef Bis; Martina Ulrychova; Milos Tichy; Tomas Tomko; Josef Bukac
Journal:  Heart Vessels       Date:  2011-01-26       Impact factor: 2.037

7.  Increased level of soluble syndecan-1 in serum correlates with myocardial expression in a rat model of myocardial infarction.

Authors:  Juan Lei; Sheng Neng Xue; Wei Wu; Shu Xian Zhou; Yu Ling Zhang; Gui Yi Yuan; Jing Feng Wang
Journal:  Mol Cell Biochem       Date:  2011-08-14       Impact factor: 3.396

8.  Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.

Authors:  M A Brown; R M Norris; P F Barnaby; G G Geary; P W Brandt
Journal:  Br Heart J       Date:  1985-10

9.  Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter.

Authors:  K Greaves; T Crake
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

10.  Infarct size estimation from serial CK MB determinations: peak activity and predictability.

Authors:  J W Fiolet; H F ter Welle; F J van Capelle; K I Lie
Journal:  Br Heart J       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.